AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results

REDWOOD CITY, Calif., March 16, 2020 /PRNewswire/ — AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today reported its fourth…

About the Author

has written 41828 stories on this site.

Copyright © 2010 Business and Corporate News.